lecce.tecnomedpuglia

Antonio Gaballo

Antonio Gaballo

Staff Researcher @ CNR Nanotec Lecce

 

Antonio Gaballo is  permanent Senior Researcher at the Institute of Nanotechnology, National Research Council (CNR), Lecce. He holds a PhD in Biochemistry and Biology and a medical specialization in Clinical Biochemistry and Chemistry.

From 2001 to 2013, Antonio Gaballo served as a researcher at the Institute of Biomembranes and Bioenergetics in Bari (CNR-IBBE, now IBIOM) where he worked on biochemical and molecular mechanisms of energy conservation in bacteria of industrial relevance and mitochondria as well as and on mitochondrial bioenergetics in certain forms of familial Parkinson’s disease. In 2013, he moved to the Institute of Nanotechnology (CNR Nanotec) based in Lecce. At CNR Nanotec, Dr. Gaballo initiated research on the relationship between solid tumors and their microenvironment, with a particular focus on the mechanisms underlying metastasis formation. His work is actually concentrated on the regulation of epithelial–mesenchymal transition (EMT), especially in response to changes in the surrounding microenvironment. He has coordinated nationally funded projects on bacterial genomics and bioenergetics (MUR-FAR DM23154, 2010-2013) and on advanced therapeutic strategies and drug delivery systems (Regione Puglia, project SISTEMA, 2015-2017). Dr. Gaballo has held academic teaching roles at the University of Bari and supervised numerous graduate and doctoral researchers

Antonio Gaballo

Staff Researcher @ CNR Nanotec Lecce

 

Antonio Gaballo is  permanent Senior Researcher at the Institute of Nanotechnology, National Research Council (CNR), Lecce. He holds a PhD in Biochemistry and Biology and a medical specialization in Clinical Biochemistry and Chemistry.

From 2001 to 2013, Antonio Gaballo served as a researcher at the Institute of Biomembranes and Bioenergetics in Bari (CNR-IBBE, now IBIOM) where he worked on biochemical and molecular mechanisms of energy conservation in bacteria of industrial relevance and mitochondria as well as and on mitochondrial bioenergetics in certain forms of familial Parkinson’s disease. In 2013, he moved to the Institute of Nanotechnology (CNR Nanotec) based in Lecce. At CNR Nanotec, Dr. Gaballo initiated research on the relationship between solid tumors and their microenvironment, with a particular focus on the mechanisms underlying metastasis formation. His work is actually concentrated on the regulation of epithelial–mesenchymal transition (EMT), especially in response to changes in the surrounding microenvironment. He has coordinated nationally funded projects on bacterial genomics and bioenergetics (MUR-FAR DM23154, 2010-2013) and on advanced therapeutic strategies and drug delivery systems (Regione Puglia, project SISTEMA, 2015-2017). Dr. Gaballo has held academic teaching roles at the University of Bari and supervised numerous graduate and doctoral researchers